Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia
Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia
复制标题
DOI:
10.1542/peds.103.3.610
复制
发表时间:
1999-03-01
期刊:
影响因子:
8
通讯作者:
Ballard, RA
中科院分区:
文献类型:
--
作者:
Banks, BA;Seri, I;Ballard, RA
Background. Severe bronchopulmonary dysplasia (BPD), which is associated with high mortality and morbidity, is thought to be the result of mechanical, inflammatory, and oxidant injury to the immature lung, and includes the development of pulmonary hypertension with vascular remodeling.Methods. A phase II pilot study was conducted to determine the effect of inhaled nitric oxide (iNO) on oxygenation in severe BPD. This was an open-labeled, noncontrolled trial to evaluate safety and determine appropriate dosing for a future randomized controlled trial. Infants were eligible for enrollment if they were greater than or equal to 4 weeks of age and ventilator dependent with a mean airway pressure of greater than or equal to 10 cm H2O and an FIO2 of greater than or equal to 0.45. Study infants received iNO (20 ppm) for 72 hours, and FIO2 was adjusted to maintain oxygen saturations of >92%. Infants who had a greater than or equal to 15% reduction in FIO2 after 72 hours received prolonged treatment with low-dose iNO, weaning by 20% every 3 days as tolerated.Findings. Sixteen preterm infants (23-29 weeks of gestation), age 1 to 7 months, were enrolled. Eleven of 16 infants had a significant increase in Fao, after 1 hour of iNO (median change, 24 mm Hg; range, -15 to 59 mm Hg; P